Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
13 Sep 2024, 21:56:09 UTC
Prior SEC filing
12 Sep 2024
Next SEC filing
31 Jan 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Chicago Pacific Founders UGP III, LLC, /s/ Michael J. Wilson, authorized signatory

Key filing fact

Chicago Pacific Founders UGP III, LLC filed Form 4 for P3 Health Partners Inc. (PIII) on 13 Sep 2024.

Key facts

  • This page summarizes Chicago Pacific Founders UGP III, LLC's Form 4 filing for P3 Health Partners Inc. (PIII).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 13 Sep 2024, 21:56.

Change

  • Previous filing in this sequence was filed on 12 Sep 2024.
  • Current net transaction value: +$81,552.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PIII transaction

Class A Common Stock

Purchase

Transaction value
$41,600
Shares
+80,000
Change %
+0.1%
Price
$0.5200
Shares after
77,105,438
Date
12 Sep 2024
Ownership
See Footnote
Footnotes
F1
PIII transaction

Class A Common Stock

Purchase

Transaction value
$39,952
Shares
+80,000
Change %
+0.1%
Price
$0.4994
Shares after
77,185,438
Date
13 Sep 2024
Ownership
See Footnote
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Chicago Pacific Founders UGP, III LLC ("UGP III") is the general partner of Chicago Founders GP III, LP ("GP III"), the general partner of each of SPV III and SPV III -A. As a result, UGP III has the power to vote and dispose of the Issuer's securities held by SPV III and SPV III -A (the "Underlying Securities"). Each of UGP III and GP III disclaims beneficial ownership for the amount in excess of their pecuniary interest in the Underlying Securities.

Footnote F2

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.49 to $0.51. The reporting person undertakes to provide P3 Health Partners Inc., any security holder of P3 Health Partners Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .